Drew Warren Rasco
Drew Warren Rasco publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research and Lung Cancer Treatments and Mutations.
- World rank
- #156,930 of 7,710,434 ranked researchers
- Rank in United States
- #59,066 of 1,627,098
- Works
- 466
- Citations
- 8.7k
- Citations per work
- 18.6
What does Drew Warren Rasco research?
Drew Warren Rasco's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23049.3%
- Medicine23049.3%
- Life Sciences12526.8%
- Everything else11123.9%
- 1Oncology31% of their works
- 2Molecular Biology16% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Radiology, Nuclear Medicine and Imaging8% of their works
- 5Immunology6% of their works
- 6Cancer Research5% of their works
Research topics
Which keywords describe Drew Warren Rasco's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Breast Cancer, Chemotherapy, Fc Receptors, Therapeutic Antibodies, EGFR Mutations and Targeted Therapy.
- KRAS Mutations
- MAP Kinase
- CAR T Cells
- Trastuzumab
- HER2
- Targeted Therapy
- Therapeutic Antibodies
- Chemotherapy
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Breast Cancer
- Fc Receptors
- EGFR Mutations
- CDK4/6 Inhibitors
- Palbociclib
- BRAF gene
- Chimeric Antigen Receptor
- Cetuximab
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Immune Checkpoint Blockade781 topic
- PD-1 and PD-L1781 topic
- Breast Cancer562 topics
- Chemotherapy532 topics
- Fc Receptors411 topic
- Therapeutic Antibodies411 topic
- EGFR Mutations291 topic
- Targeted Therapy291 topic
- CDK4/6 Inhibitors281 topic
- HER2281 topic
- Palbociclib281 topic
- Trastuzumab281 topic
- BRAF gene261 topic
- CAR T Cells261 topic
- Chimeric Antigen Receptor261 topic
- MAP Kinase261 topic
- Cetuximab251 topic
- KRAS Mutations251 topic
Where does Drew Warren Rasco work?
Drew Warren Rasco's main affiliation in the publication record is South Texas Accelerated Research Therapeutics, United States.
How many publications and citations does Drew Warren Rasco have?
OpenAlex counts 466 works and 8,650 citations for Drew Warren Rasco, an h-index of 41, ranking #156,930 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Drew Warren Rasco. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.